1. Home
  2. PDSB vs HBIO Comparison

PDSB vs HBIO Comparison

Compare PDSB & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDSB
  • HBIO
  • Stock Information
  • Founded
  • PDSB 2005
  • HBIO 1901
  • Country
  • PDSB United States
  • HBIO United States
  • Employees
  • PDSB N/A
  • HBIO N/A
  • Industry
  • PDSB Biotechnology: Pharmaceutical Preparations
  • HBIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • PDSB Health Care
  • HBIO Industrials
  • Exchange
  • PDSB Nasdaq
  • HBIO Nasdaq
  • Market Cap
  • PDSB 58.7M
  • HBIO 61.2M
  • IPO Year
  • PDSB N/A
  • HBIO 2000
  • Fundamental
  • Price
  • PDSB $1.16
  • HBIO $0.59
  • Analyst Decision
  • PDSB Strong Buy
  • HBIO Buy
  • Analyst Count
  • PDSB 3
  • HBIO 1
  • Target Price
  • PDSB $10.00
  • HBIO $4.50
  • AVG Volume (30 Days)
  • PDSB 794.1K
  • HBIO 368.1K
  • Earning Date
  • PDSB 03-27-2025
  • HBIO 03-12-2025
  • Dividend Yield
  • PDSB N/A
  • HBIO N/A
  • EPS Growth
  • PDSB N/A
  • HBIO N/A
  • EPS
  • PDSB N/A
  • HBIO N/A
  • Revenue
  • PDSB N/A
  • HBIO $94,135,000.00
  • Revenue This Year
  • PDSB $5,518.68
  • HBIO N/A
  • Revenue Next Year
  • PDSB N/A
  • HBIO $7.97
  • P/E Ratio
  • PDSB N/A
  • HBIO N/A
  • Revenue Growth
  • PDSB N/A
  • HBIO N/A
  • 52 Week Low
  • PDSB $1.05
  • HBIO $0.56
  • 52 Week High
  • PDSB $4.42
  • HBIO $4.70
  • Technical
  • Relative Strength Index (RSI)
  • PDSB 40.47
  • HBIO 25.97
  • Support Level
  • PDSB $1.19
  • HBIO $0.56
  • Resistance Level
  • PDSB $1.41
  • HBIO $0.67
  • Average True Range (ATR)
  • PDSB 0.10
  • HBIO 0.05
  • MACD
  • PDSB -0.01
  • HBIO 0.02
  • Stochastic Oscillator
  • PDSB 27.63
  • HBIO 16.59

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.

Share on Social Networks: